FHI Ventures

FHI Ventures is a social enterprise accelerator and impact investing subsidiary of FHI 360 rather than a drug-development biotech company. It supports early-stage businesses with capital, mentorship, and access to FHI 360’s technical expertise and global footprint, with a stated focus on generating both social and financial returns. Its sector exposure includes healthcare alongside education, economic development, and technology for social good. Based on available public information, FHI Ventures does not appear to run an internal therapeutic pipeline, clinical-stage drug programs, or proprietary biopharma assets. For a biotech analyst, the most relevant framing is that FHI Ventures is a health-adjacent impact investment and venture support vehicle, not an operating pharma or biotech developer.